Cargando…
Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133(+) cells in ischemic refractory cardiomyopathy trial (RECARDIO)
BACKGROUND: Cell therapy with bone marrow (BM)-derived progenitors has emerged as a promising therapeutic for refractory angina (RA) patients. In the present study, we evaluated the safety and preliminary efficacy of transcatheter delivery of autologous BM-derived advanced therapy medicinal product...
Autores principales: | Bassetti, Beatrice, Carbucicchio, Corrado, Catto, Valentina, Gambini, Elisa, Rurali, Erica, Bestetti, Alberto, Gaipa, Giuseppe, Belotti, Daniela, Celeste, Fabrizio, Parma, Matteo, Righetti, Stefano, Biava, Lorenza, Arosio, Maurizio, Bonomi, Alice, Agostoni, Piergiuseppe, Scacciatella, Paolo, Achilli, Felice, Pompilio, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137884/ https://www.ncbi.nlm.nih.gov/pubmed/30217223 http://dx.doi.org/10.1186/s13287-018-0969-z |
Ejemplares similares
-
Cell Therapy for Refractory Angina: A Reappraisal
por: Bassetti, Beatrice, et al.
Publicado: (2017) -
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133(+) Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy
por: Belotti, Daniela, et al.
Publicado: (2015) -
Son of a Lesser God: The Case of Cell Therapy for Refractory Angina
por: Bassetti, Beatrice, et al.
Publicado: (2021) -
New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence
por: Rurali, Erica, et al.
Publicado: (2020) -
GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy
por: Gaipa, Giuseppe, et al.
Publicado: (2010)